Compare Immunovant Inc. Common Stock (IMVT) vs Tripadvisor Inc Common Stock (TRIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Tripadvisor Inc Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Tripadvisor Inc Common Stock trades at $8.94 (market cap $1.01B). The key difference: Immunovant Inc. Common Stock is far larger — about 6.6× Tripadvisor Inc Common Stock's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Tripadvisor Inc Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Tripadvisor Inc Common Stock for 57 Days on average.
| IMVT | TRIP | |
|---|---|---|
Market Cap | $6.62B | $1.01B |
Volume | 1,131,364 | 3,004,748 |
Sector | Health | Consumer Cyclical |
52-Week High | $44.96 | $16.72 |
52-Week Low | $17.03 | $8.04 |
Typical Hold Time | 0 Days | 57 Days |
Enterprise Value | $5.72B | $1.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TripAdvisor (TRIP) trades at $8.96, up 5.16% on the day but near its 52-week low of $8.27. The stock is technically bearish with recent earnings misses and a net cash outflow trend. Revenue grew to $1.89B in 2025 with a net income margin of 2.11%, but profitability remains volatile. Analyst consensus is a 'Hold' with a $13.58 price target, indicating cautious optimism amid competitive pressures from AI-driven travel platforms.
The outlook is mixed: valuation ratios like P/S of 0.57 suggest potential undervaluation, but persistent earnings misses and declining cash flow pose risks. Upside depends on stabilizing core offerings and successful subsidiary sales, while competition and search-related pressures threaten growth. Investors should weigh low valuation against execution challenges in a dynamic travel sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Tripadvisor Inc Common Stock
TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →
